Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China · Delayed Price · Currency is CNY 7.42
+0.17 (2.34%)
May 12, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -6.93 | -18.54 | 31.09 | -10.75 | 18.23 | -118.91 |
Depreciation & Amortization | 128.94 | 128.94 | 112.01 | 112.09 | 138.27 | 167.86 |
Other Amortization | 1.9 | 1.9 | 4.94 | 6.22 | 4.61 | 9.03 |
Loss (Gain) From Sale of Assets | 0.1 | 0.1 | -3.01 | -0.05 | 0.06 | 0.23 |
Asset Writedown & Restructuring Costs | 22.65 | 22.65 | 7.87 | 12.95 | 0.43 | 82.47 |
Loss (Gain) From Sale of Investments | -1.76 | -1.76 | -12.21 | -5.38 | -156.82 | 2.28 |
Provision & Write-off of Bad Debts | - | - | 1.44 | -16.78 | -0.17 | 34.95 |
Other Operating Activities | 26.27 | 1.22 | 11.25 | 24.46 | 54.6 | 115.84 |
Change in Accounts Receivable | -1.75 | -1.75 | -25.38 | 27.66 | 154.07 | 11.84 |
Change in Inventory | -23.63 | -23.63 | -2.6 | 13.39 | -28.43 | 13.84 |
Change in Accounts Payable | 11.96 | 11.96 | -51.76 | -5.88 | 57.23 | -82.71 |
Operating Cash Flow | 157.73 | 121.07 | 69.19 | 154.4 | 249.77 | 216.93 |
Operating Cash Flow Growth | - | 74.97% | -55.19% | -38.18% | 15.14% | -46.27% |
Capital Expenditures | -277.19 | -277.23 | -377.4 | -394.17 | -197.78 | -162.98 |
Sale of Property, Plant & Equipment | 0.11 | 0.11 | 0.79 | 0.22 | 0.02 | 0.02 |
Cash Acquisitions | - | - | -9.1 | - | -4.06 | -91.15 |
Divestitures | - | - | - | - | 1,201 | - |
Investment in Securities | 85.61 | 122.61 | 287.97 | 519.48 | -1,432 | -0.62 |
Other Investing Activities | 19.43 | 30.82 | 16.78 | 16.68 | 21.91 | 0.19 |
Investing Cash Flow | -172.04 | -123.68 | -80.95 | 142.22 | -411.31 | -254.53 |
Long-Term Debt Issued | - | 99.85 | 35 | 89.35 | 429.9 | 901.5 |
Total Debt Issued | 99.85 | 99.85 | 35 | 89.35 | 429.9 | 901.5 |
Long-Term Debt Repaid | - | -73 | -49.83 | -115 | -710.28 | -825.39 |
Net Debt Issued (Repaid) | -17.08 | 26.85 | -14.83 | -25.65 | -280.38 | 76.11 |
Issuance of Common Stock | - | - | - | 0.95 | - | - |
Repurchase of Common Stock | - | - | - | -39.06 | -61.05 | - |
Common Dividends Paid | -49.1 | -49.1 | -34.55 | -51.06 | -61.94 | -69.98 |
Other Financing Activities | 0.81 | 1.38 | 92.43 | -99.42 | 480.24 | 30.49 |
Financing Cash Flow | -65.36 | -20.87 | 43.05 | -214.25 | 76.87 | 36.62 |
Foreign Exchange Rate Adjustments | -2.98 | -2.38 | -2.62 | 0.6 | 2.08 | -0.33 |
Net Cash Flow | -82.65 | -25.86 | 28.67 | 82.97 | -82.58 | -1.31 |
Free Cash Flow | -119.46 | -156.16 | -308.2 | -239.77 | 51.99 | 53.95 |
Free Cash Flow Growth | - | - | - | - | -3.64% | -55.29% |
Free Cash Flow Margin | -14.18% | -18.76% | -37.30% | -30.12% | 4.43% | 2.85% |
Free Cash Flow Per Share | -0.24 | -0.32 | -0.63 | -0.49 | 0.11 | 0.11 |
Cash Income Tax Paid | 26.87 | 26.32 | 35.63 | 31.9 | 87.51 | 89.61 |
Levered Free Cash Flow | -104.42 | -146.12 | -258.8 | -240.05 | 778.97 | 70.6 |
Unlevered Free Cash Flow | -104.42 | -146.12 | -254.73 | -238.29 | 791.32 | 92.11 |
Change in Working Capital | -13.45 | -13.45 | -84.19 | 31.64 | 190.57 | -76.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.